A thirteen-gene expression signature predicts survival of patients with pancreatic cancer and identifies new genes of interest.

A thirteen-gene expression signature predicts survival of patients with pancreatic cancer and identifies new genes of interest.

Currently, prognostication for pancreatic ductal adenocarcinoma (PDAC) is based upon a coarse clinical staging system. Thus, more accurate prognostic tests are needed for PDAC patients to aid treatment decisions.Affymetrix gene expression profiling was carried out on 15 human PDAC tumors and from th...

Full description

Bibliographic Details
Main Authors: Timothy E Newhook, Edik M Blais, James M Lindberg, Sara J Adair, Wenjun Xin, Jae K Lee, Jason A Papin, J Thomas Parsons, Todd W Bauer
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4152146?pdf=render

Similar Items

Similar Items